Ledger.Open graph →
SEC Form D · filed May 7, 2018

Clear Creek Bio, Inc

Offering
$6.1M
Sold
$6.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Vikram S. Kumar · Cambridge, MAExec · DirectorAndrew S. Levin · Cambridge, MADirectorBurt S. Adelman · Cambridge, MADirectorDavid S. Scadden · Cambridge, MADirectorMichael Gingrich · St. Louis, MODirectorGuillaume Le Bouar · Luxembourg, LuxembourgDirectorRichard Q. Opler · Parker, CODirectorLaurent Forget · Luxembourg, LuxembourgExec · DirectorSteve Hulteng · Kirkland, WADirectorChanning T. Lushbough · Pasadena, CAExec · DirectorSamuel Hodges · San Francisco, CADirectorNicholas Shalek · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗